RNA G-quadruplexes form scaffolds that promote neuropathological α-synuclein aggregation
Kazuya Matsuo,Sefan Asamitsu,Kohei Maeda,Hiroyoshi Suzuki,Kosuke Kawakubo,Ginji Komiya,Kenta Kudo,Yusuke Sakai,Karin Hori,Susumu Ikenoshita,Shingo Usuki,Shiori Funahashi,Hideki Oizumi,Atsushi Takeda,Yasushi Kawata,Tomohiro Mizobata,Norifumi Shioda,Yasushi Yabuki
DOI: https://doi.org/10.1016/j.cell.2024.09.037
IF: 64.5
2024-11-27
Cell
Abstract:Synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are triggered by α-synuclein aggregation, triggering progressive neurodegeneration. However, the intracellular α-synuclein aggregation mechanism remains unclear. Herein, we demonstrate that RNA G-quadruplex assembly forms scaffolds for α-synuclein aggregation, contributing to neurodegeneration. Purified α-synuclein binds RNA G-quadruplexes directly through the N terminus. RNA G-quadruplexes undergo Ca2+-induced phase separation and assembly, accelerating α-synuclein sol-gel phase transition. In α-synuclein preformed fibril-treated neurons, RNA G-quadruplex assembly comprising synaptic mRNAs co-aggregates with α-synuclein upon excess cytoplasmic Ca2+ influx, eliciting synaptic dysfunction. Forced RNA G-quadruplex assembly using an optogenetic approach evokes α-synuclein aggregation, causing neuronal dysfunction and neurodegeneration. The administration of 5-aminolevulinic acid, a protoporphyrin IX prodrug, prevents RNA G-quadruplex phase separation, thereby attenuating α-synuclein aggregation, neurodegeneration, and progressive motor deficits in α-synuclein preformed fibril-injected synucleinopathic mice. Therefore, Ca2+ influx-induced RNA G-quadruplex assembly accelerates α-synuclein phase transition and aggregation, potentially contributing to synucleinopathies.